Nexium

Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical’s Copaxone is the most affected drugs in terms of sales as the sales of 2013 has increased to 4.328 billions bearing the highest loss. Least affected Drug is AbbVie’s Trilipix which has faced the decrease in sales from 1.098 billions to 303 millions.

Welcome!

We are Market Research & Business Consulting firm and serves as a Knowledge Partner across the value chain of Pharmaceutical Industry. Keep yourself updated with our blog. For more information visit www.delveinsight.com

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.